Details
Description
This analysis aimed to characterize users of 51 new molecular entities (NMEs) that were approved by the FDA in 2021 in the TriNetX Live™ platform. This query ran on January 19, 2024 and the analysis contains two reports:
- Report 1: This report contains data from 43 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with No Shift from January 1, 2021 to the most recently available data, January 19, 2024.
- Report 2: This report contains contains data from 50 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network with Minimal Shift from December 18, 2020 to the most recently available data, January 19, 2024.